At Kern Pharma Biologics we want to help the agents of the health system jointly define a common framework that allows the development of biosimilar medicines with the aim of promoting value-based healthcare.
At Kern Pharma Biologics we want to help the agents of the health system jointly define a common framework that allows the development of biosimilar medicines with the aim of promoting value-based healthcare.